News

Weill Cornell Medicine scientists have built the first global database of clinical trials testing a rapidly expanding approach to cancer treatment that involves genetically modifying immune cells to recognize specific targets on a patient’s cancer cells and attack them.

Weill Cornell Medicine scientists have developed a machine-learning algorithm capable of predicting biological targets of prospective drug molecules.

Awards, honors, prizes and achievements for the month of December.

Medical schools evaluating the merits of eliminating tuition, as opposed to pursuing debt-free initiatives, should approach the debate in the same way physicians and scientists engage in medicine: with empirical data, according to new commentary by leaders at Weill Cornell Medicine.

A five-year, $3 million grant from the National Institute on Aging will fund work developing innovative approaches to pain management.

Scientists at Weill Cornell Medicine have discovered how a key transcription factor protein called KLF4 helps “reprogram” skin cells into stem cells, according to a new study.

African American patients who underwent knee-replacement surgery were several times more likely than white patients of similar age to be discharged to inpatient facilities for post-operative care and rehabilitation rather than home, according to a large study from a team led by Weill Cornell Medicine investigators. 

Weill Cornell Medicine and the University of Virginia School of Medicine have received a grant from the National Heart, Lung, and Blood Institute and Three Lakes Partners, a philanthropic family organization, to fund the first precision medicine research initiative aiming to transform the diagnosis and treatment of interstitial lung diseases, particularly idiopathic pulmonary fibrosis.

Dr. Yoon Kang has been appointed senior associate dean for medical education at Weill Cornell Medicine, effective Dec. 9.

Neurons have a special mechanism that allows them to quickly boost energy production to support bursts of brain activity, according to a new study from scientists at Weill Cornell Medicine.

Dr. Jyotishman Pathak is a researcher who jokingly says that he’s “still learning to fake business” after launching a new company just six months ago. Though new to the business world, by any measure, he’s already a success.

Dr. Carl Nathan, chairman of the Department of Microbiology and Immunology at Weill Cornell Medicine, has been awarded the Sanofi – Institut Pasteur Senior International Scientist Award for Biomedical Research in Microbiology and Infection.

More diverse applicants will be encouraged to apply to M.D.-Ph.D. programs if medical schools publish admissions statistics on their websites, a team from Weill Cornell Medicine says in a viewpoint published Dec. 9 in the Journal of Clinical Investigation.

Awards, honors, prizes and achievements for the month of November.

A change in the protein composition of chromatin—the condensed, packaged form of DNA in the nucleus—boosts the expression of metastasis-related genes; blocking this change appears to stop tumor cells from forming new tumors in mice, suggests a study by Weill Cornell Medicine investigators. 

A new technology developed by Weill Cornell Medicine and Max Planck Institute for Medical Research scientists allows the controlled, on-and-off “switching” of neural receptors with unprecedented efficiency and precision. 

Weill Cornell Medicine has been awarded a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research to create a center aimed at developing technology to help older adults who have cognitive impairments (CIs).

Dr. Vivian J. Bea, an expert in breast cancer disparities, has been named section chief of breast surgical oncology at NewYork-Presbyterian Brooklyn Methodist Hospital. She also serves as an assistant professor of surgery at Weill Cornell Medicine.

The gene mutation that underlies a puzzling disorder featuring skin, brain and other abnormalities has been discovered by a team of scientists from Weill Cornell Medicine and the Fédération Hospitalo-Universitaire TRANSLAD (FHU-TRANSLAD) in France.

A prestigious Cancer Moonshot grant from the National Cancer Institute’s Immuno-Oncology Translational Network will enable investigators to explore the mechanisms that allow slow-growing lung cancer lesions to progress into aggressive malignancies and identify new therapeutic strategies to intercept the transition.